COGT

Cogent Biosciences, Inc. Common Stock

37.97

USD

COGT Earnings Reports

Positive Surprise Ratio

COGT beat 14 of 31 last estimates.

45%

Next Report

Date of Next Report

Feb 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.52

Implied change from Q3 25 (Revenue/ EPS)

+4.00%

Implied change from Q4 24 (Revenue/ EPS)

+333.33%

Cogent Biosciences, Inc. Common Stock earnings per share and revenue

On Nov 03, 2025, COGT reported earnings of -0.50 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 7.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.91% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an increase of 4.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Cogent Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Cogent Biosciences, Inc. Common Stock reported EPS of -$0.50, beating estimates by 7.1%, and revenue of $0.00, 0% as expectations.

How did the market react to Cogent Biosciences, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -4.91%, changed from $16.30 before the earnings release to $15.50 the day after.

When is Cogent Biosciences, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 23, 2026.

What are the forecasts for Cogent Biosciences, Inc. Common Stock's next earnings report?

Based on 14 analysts, Cogent Biosciences, Inc. Common Stock is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.